ArticleCancer medicine2016

Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.

Yusuke Nitta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.